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Summary The c-fgr protooncogene is a member of the c-src family of tyrosine kinases. Expression of c-fgr
was studied in a series of Epstein-Barr virus (EBV) negative Burkitt's lymphoma cell lines and their EBV-
converted derivatives. Two transcripts, of 2.9kb and 3.5kb, were present at dramatically elevated levels
following EBV-conversion.
The structure of the c-fgr transcripts was studied by the isolation and nucleotide sequence analysis of
cDNA clones. This indicated that the c-fgr protein encoded by the mature mRNA would contain 529 amino
acids and have a molecular weight of approximately 58,000. The N-terminus of the predicted c-fgr protein has
low amino acid homology with the N-termini of other members of this family of proteins, suggesting a cell
specific function for the N-terminal domain. Analysis of the c-fgr cDNA clones also revealed the presence of
alternative functional polyadenylation signals, although the use of these does not account for the size
difference between the two major c-fgr transcripts.
A variety of agents, including antigens, lymphokines and
mitogens, can activate small resting B-lymphocytes to pro-
liferate and progress to a terminally differentiated state. The
molecular mechanisms whereby signals at the B-lymphocyte
cell surface generate changes in DNA and RNA synthesis
are of considerable interest. B-lymphocyte activation is
accompanied by the appearance of a range of cell surface
molecules, such as CD23 and Blast-I (Swendeman &
Thorley-Lawson, 1987), and it is probable that some of these
activation markers represent receptors for growth and
differentiation factors. It has been shown, for example, that
a fragment of CD23 shed from the surface of activated B-
lymphocytes can act as an autocrine B cell growth factor for
normal and transformed B-lymphocytes (Swendeman &
Thorley-Lawson, 1987).
Within the cell, a number of changes which may be
involved in signalling have been described. These include
increases in phosphatidylinositol 4,5-bisphosphate hydrolysis,
intracellular free Ca2+ and protein kinase C activation
(Ransom et al., 1986). It is likely that a range of other
intracellular molecules are also involved in signalling during
B-lymphocyte activation. One candidate is the cellular proto-
oncogene c-fgr, which is a member of a family of genes
encoding intracellular proteins with tyrosine kinase activity
(Nishizawa et al., 1986). Transcripts of c-fgr are induced in
B-lymphocytes immortalised by Epstein-Barr virus (EBV)
and in EBV-negative Burkitt's lymphoma (BL) cell lines
converted with EBV in vitro (Cheah et al., 1986). Both of
these events bear many features in common with B-
lymphocyte activation (Thorley-Lawson & Mann, 1985),
involving changes in growth properties (Zeuthen, 1983) and
in the expression of B-lymphocyte cell surface activation
markers (Rowe et al., 1986).
Cheah et al. (1986) showed that EBV converts of the
EBV-negative BL cell lines Ramos and BJAB contained a
3 kb transcript homologous to the cellular proto-oncogene
c-fgr, which was undetectable in Ramos and BJAB
themselves. Ramos and BJAB and their converts are long-
established cell lines, and have had the opportunity to
accumulate phenotypic changes unrelated to their initial
EBV conversion. We have therefore studied changes in c-fgr
expression in a series of recently established EBV-negative
BL cell lines (Calender et al., 1987), freshly converted with
the B95-8 strain of EBV. These cell lines have been well
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characterised with respect to the pattern of EBV gene
expression within them (Murray et al., 1988), to their growth
properties and to the B-lymphocyte activation markers which
they express (Rowe et al., 1986; Calender et al., 1987). We
also report here the isolation and sequencing of c-fgr cDNA
clones, a necessary first step in the characterisation of the
structure of the c-fgr protein and of its function in B-
lymphocyte activation, and in the mapping of the c-fgr gene
for studies of its regulation during B-lymphocyte activation.
We describe features of the 5' untranslated region and the 5'
coding region of c-fgr mRNA, and demonstrate that the 3'
untranslated region contains alternative polyadenylation
sites.
Materials and methods
Cell lines
EBV-negative BL cell lines IARC BL2, IARC BL31 and
IARC BL41, and their EBV-converted sublines IARC BL2-
B95/1, IARC BL31-B95/1 and IARC BL41-B95/1, were a
gift from Prof. A.B. Rickinson, Cancer Research Campaign
Laboratories, Department of Cancer Studies, The Medical
School, Birmingham. They were maintained in RPMI 1640
medium supplemented with 15% (v/v) foetal calf serum
(Sera-Lab) and 2mM L-glutamine.
RNA preparation
Total RNA was purified from washed cell pellets using the
guanidinium isothiocyanate method of Chirgwin et al.
(1979). Polyadenylated RNA was isolated by affinity
chromatography on oligo-dT cellulose (Collaborative
Research Ltd.) according to Craig et al. (1976).
Northern blotting
Polyadenylated RNA (2jg per track) was electrophoresed on
a 1% (w/v) agarose MOPS-formaldehyde gel and blotted on
to Biodyne membrane (PALL) essentially as described by
Taylor et al. (1984). Filters were probed overnight at 65°C
with 32P-labelled antisense RNA, prepared as described
below, in hybridisation buffer (60% (v/v) formamide, 5 x
SSC, 5 x Denhardt's solution, 20mM sodium phosphate pH
6.8, 1% (w/v) SDS, 7% (w/v) dextran sulphate, 100jgml- 1
single-stranded sonicated herring testis DNA, 100ugml-l E.
coli tRNA, 10jugml- 1 poly A). Final washes were performed
at 65°C in 0.1 x SCC/1% (w/v) SDS.
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Antisense RNA probes
Plasmid pFBS2 is a subclone, in the plasmid vector pGEM1,
of an 849bp Bam HI-Sma I fragment of the v-fgr gene,
containing only sequences from the tyrosine kinase encoding
domain. Antisense RNA was synthesised by incubating 1 pg
Sma I-linearised pFBS2 DNA at 37°C for 2h in 40mM Tris-
HCl (pH 7.5) containing 2mM spermidine, 20mM dithio-
threitol, 0.43mM UTP, 0.43mM ATP, 0.43mM GTP, 5,UM
CTP, 1 unit p1- RNAse inhibitor (BCL Ltd.), 70pCi 32P
CTP (NEN Ltd.), 0.2 units p1 1 SP6 RNA polymerase (BCL
Ltd.). Template was digested by incubation with I pg
RNAse-free DNase (Miles) at 37°C for 10min, and unincor-
porated nucleotides were removed, following phenol extrac-
tion and ether extraction, by ethanol precipitation.
Plasmid pF3.4 is a subclone, in the plasmid vector
Bluescript SK M13+ (Stratagene, San Diego), of a 280bp
Rsa I-Eco RI fragment encompassing the 3' end of pFal
and 9bp of sequence shared by pFal and pFclI (see Figures
2 & 5. Antisense RNA was synthesised as above, using
Bam HI-linearised pF3.4 DNA as a template, with 0.2 units
pl- 1 T3 RNA polymerase (Stratagene, San Diego) and
including 50mM sodium chloride and 8mM magnesium
chloride in the incubation buffer.
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Figure 1 Northern blots of polyadenylated RNA isolated from
Raji (lane a), Daudi (lane b), BL41 (lanes c and e), BL41-B95/1
(lanes d and f), BL2 (lanes g and i), BL2-B95/1 (lanes h, j and
m), BL31-B95/1 (lane k) and BL31 (lane l) cells. Lanes a, b, c, d,
g, h, k, 1 and m were probed for c-fgr transcripts with 32P_
labelled antisense RNA synthesised from Sma I-linearised pFBS2
DNA. Lanes e, f, i and j are lanes c, d, g and h, respectively,
reprobed with the 32P-labelled mouse actin cDNA clone pAM91
(Humphries et al., 1981) to show that the polyadenylated RNA
in each track was intact and present in equal quantities. Washing
conditions were as described in the text. Sizes of transcripts are
indicated in kilobases.
Construction of cDNA libraries
Blunt-ended, EcoRI-methylated, double-stranded cDNA was
synthesised from 2/pg polyadenylated RNA extracted from
BL2-B95/1 cells. It was then ligated to Eco RI linkers and
cloned into the Eco RI site of the bacteriophage vector Agt
10, according to Watson & Jackson (1985). The ligated
molecules were packaged in vitro and the resultant bacterio-
phage particles plated out according to Huynh et al. (1985),
yielding a cDNA library of 2 x 105 pfu.
The RPMI 4265 cDNA library was constructed in Agt 10
by Clontech Laboratories Inc. (California) from poly-
adenylated RNA isolated from the EBV-positive lympho-
blastoid cell line RPMI 4265, and was a gift from Dr P.
Beverley, ICRF Human Tumour Immunology Unit,
University College, London.
Isolation of c-fgr cDNA clones
The cDNA libraries were plated at high density and screened
according to Benton & Davis (1977). The hybridisation
probe was pFBS2 DNA, radiolabelled with 32P-dCTP by the
oligonucleotide method of Feinberg & Vogelstein (1984).
Hybridisation was performed at 65°C in 6 x SSC containing
Sx Denhardt's solution and 0.1% (w/v) SDS. Final washes
were performed at 65°C in 2 x SSC containing 1% (w/v)
SDS.
DNA sequencing
Single stranded templates were prepared from Bluescript SK
M13' sub-clones and dideoxy-sequencing was performed
using modified T7 DNA polymerase (Sequenase; United
States Biochemical Corporation, Ohio). Sequences were
analysed with the aid of the Beckman MicroGenie sequence
analysis programme (Queen & Korn, 1984). Oligonucleotides
used as sequencing primers, whether homologous to vector
or insert sequences, were kindly synthesised for us by Dr
Len Hall, Department of Biochemistry, University of Bristol.
Results
Expression of c-fgr mRNA following EBV-conversion
Radiolabelled antisense RNA synthesised from the v-fgr
tyrosine kinase domain probe, pFBS2, hybridised to a single
2.9kb transcript in Raji and Daudi cells (Figure 1, lanes a
and b), as previously reported by Cheah et al. (1986).
However the pattern of transcripts in the EBV-converted cell
lines was more complicated (Figure 1, lanes d, h and k). All
three EBV-converted lines contained transcripts at 2.9kb and
3.5kb. These hybrids were stable when blots were washed in
0.1 x SSC/l % SDS at 80°C and treated with RNase A
(20,pg/ml; Sigma), as shown in Figure 1 (lane m), suggesting
that they both derive from the c-fgr gene. A third transcript,
of 3.9kb, was visible in BL2-B95/1 cells only (Figure 1, lane
h). This hybrid was not stable following RNase A treatment
(Figure 1, lane m), suggesting that it derives from a related
member of the tyrosine kinase gene family to which c-fgr
belongs. It is clear from Figure 1 (lanes c, g and 1), that low
levels of the 2.9 and 3.5kb c-fgr transcripts are present in
BL2, BL31 and BL41 cells, but that there is significant
induction upon EBV-conversion. Reprobing of blots with a
32P-labelled actin probe (Figure 1, lanes e, f, i and j)
demonstrated that the polyadenylated RNA in each lane was
intact and present in equal quantities, confirming that the
induction of c-fgr transcripts upon EBV-conversion is a real
phenomenon.
Isolation and nucleotide sequencing of c-fgr cDNA clones
In order to determine the relationship of the 2.9kb and 3.5
kb transcripts to each other and to derive information about
the 5' end of the c-fgr coding region, we screened two cDNA
libraries for c-fgr cDNA clones. Ten positively-hybridising
recombinant phage were found amongst 120,000 colonies
screened. These were plaque purified, and their inserts were
excised with Eco RI and subcloned into the Eco RI site of
the plasmid vector Bluescript SK M13+. Restriction maps of
the inserts of the three longest clones (pFal, pFcl l &
pFd97), each from the RPMI 4265 cDNA library, are shown
in Figure 2. Together, the three clones span 2,347bp and the
restriction maps of their central regions are colinear with
previously published partial restriction maps of the c-fgr
transcript, predicted from the sequences of genomic clones
(Parker et al., 1985; Nishizawa et al., 1986).
Single stranded templates were prepared from pFal, pFa4
(insert of pFAI cloned in the opposite orientation), pFcll
and pFd97 and dideoxy-sequencing was performed.
Sequences from regions of overlap with previously published
genomic sequences (Parker et al., 1985; Nishizawa et al.,
1986) exhibited 100% homology (data not shown). The
sequence of the 5' end of the c-fgr mRNA, derived from
clones pFd97 and pFa4, is shown in Figure 3. Clone pFd97
contains 153bp of 5' untranslated region. The ATG codon
at nucleotides 154 to 156 is likely to be the correct initiation
codon since all three reading frames contain upstream
termination codons, the remaining two reading frames
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Figure 2 Restriction maps of the c-fgr cDNA clones pFd97,
pFcl 1 and pFal and of the subclone pF3.4. The deduced
structure of the c-fgr mRNA is indicated below. Distances are
given in base pairs. Restriction sites are: B=Bam HI,
Bs=Bst ElI, E=Eco RI, P=Pst I, Pv=Pvu II, R=Rsa I,
S=Sma I.
30 60
AGACCAAAGCACTGATGTGACGGAACCATCAGCCAGGCAACTGGACCTGGTGGATCCAGG
90 120
AAGACTTTCTGGAAGAGGTCTCTGACCCCTCCCAAGGATCATGCCGCAGCCCCACTGACC
150 180
CAGGAGTAGGGGCCTAAGGGCAGGGAACCTGGAATGGGCTGTGTGTTCTGCAAGAAATTG
M G C V F C K K L
210 240
GAGCCGGTGGCCACGGCCAAGGAGGATGCTGGCCTGGAAGGGGACTTCAGAAGCTACGGG
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270 300
GCAGCAGACCACTATGGGCCTGACCCCACTAAGGCCCCGCCTGCATCCTCATTTGCCCAC
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ATCCCCAACTACAGCAACTTCTCCTCTCAGGCCATCAACCCTGGCTTCCTTGATAGTGGC
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390 420
ACCATCAGGGGTGTGTCAGGGATTGGGGTGACCCTGTTCATTGCCCTGTATGACTATGAG
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GCTCGAACTGAGGATGACCTCACCTTCACCAAGGGCCAGAAGTTCCACATCCTGAACAAT
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510 540
ACTGAAGGTGACTGGTGGGAGGCTCGGTCTCTCAGCTCCGGAAAAACTGGCTGCATTCCC
T E G D W W E A R S L S S G K T G C I P
570 600
AGCAACTACGTGGCCCCTGTTGACTCAATCCAAGCTGAAGAGTGGTACTTTGGAAAGATT
S N Y V A P V D S I Q A E E W Y F G K I
630 660
GGGAGAAAGGATGCAGAGAGGCAGCTGCTTTCACCAGGCAACCCCCAGGGGGCCTTTCTC
G R K D A E R Q L L S P G N P Q G A F L
ATTCGGGAAAGCGAGACCACCAAAG
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Figure 3 Nucleotide sequence of the 5' end of the c-fgr cDNA
clones pFd97 (nucleotides 1-250) and pFa4 (nucleotides 191-
685), with predicted amino-acid sequence. The two ATG codons
in the 5' untranslated region are underlined.
contain downstream termination codons, and the reading
frame indicated is in phase with previously predicted amino-
acid sequence (Nishizawa et al., 1986). In addition, this
initiation codon obeys the rules of Kozak (1987). Taking
these sequence data with those of Nishizawa et al. (1986),
the c-fgr protein would contain 529 amino-acids and would
have a predicted molecular weight of -58,000. As shown in
Figure 4, the N-terminal 75 amino-acids of the predicted c-
fgr protein have low homology with the N-termini of the
predicted human lyn, hck, fyn, c-src and c-yes proteins. In
contrast, our data and previously published sequence indi-
cate strong homology between these proteins from amino-
1 10 20 30 40 50
c-fgr MGCVFCK-----KL--------EPVATAKEDAGLE-GDFRSYGAADHYGPDPT-KARPASSFAH- I
lvn IKS -----GK--------DSLSDDGV LKTQ-PV- NTERTI- VR -SNKQQR--P--V
hck MKS -----F -------- QVGGNTFSKTETS-A--- -PHCPV V -STIKPGPNS --
fyn Q -----DK-------- ATKLTE RD SLNQ--C- --SGYR T -PQHYP FGVTS
c-src SNKS ----P DASQRRRSL - ENVHG GGAFPASQTPSKPA--SADGHRGPS AFAPA-A
c-yes IKS ENKSPAIKYRPENTP S SVSHY A PTTVSPCPSSSAK TAVNFSSLSMTP GG-S
60 70 80 90 100
c - gr PNYSNFSSQAINPGF--------LDSGTIRGVSGIGVTLFIALYDYEARTEDDLTFTKGEKFHILN
lyn E- Q-LLPGQR-- ---------Q-- -KDPEEQ DIV-V P DGIHP S K MKV E
hck - -T-PG R--E---------A- S---ED- -I-V-V IHHE S Q DQMVV E
fvn N HAAGGQGLTVFGGVNSSSHT L TRG T V S H Q
c-src AEPKL GGFNSSD-T------- VT PQRA PLAG T V S T S K RLQ V
c-yes SGVTP GGASSSFSV--------VP SYPA LTG- I V TE S K R Q I
110 120 130 140 150 160 170
c - fgr NTEGDWWEARSLSSGKTGCIPSNYVAPVDSIQAEEWYFGKIGRKDAERQLLSPGNPQGAFLIRESE
lyn EH- E K K LTK E F KLNTLET F KD T A SA
hck ES- E K ATR E Y R LET F KG S A ML S M D
fyn SS TT E Y L F R T
c-src L H T Q Y S T RES L NAE R T V
c-Yes IAT N Y A M L N QR I V
% amino acid homology with:
c-fgr c-fgr
(amino acids 1-75) (amino acids 76-529)
human lyn
human hck
human fyn
human c-src
chicken c-src
human c-yes
19
23
29
15
60
62
76
74
76 17
Figure 4 Optimal alignment of N-terminal 174 amino-acids of
predicted c-fgr protein with predicted N-terminal amino-acid
sequences of human lyn (Yamanashi et al., 1987), hek (Quintrell
et al., 1987), fyn (Semba et al., 1987), c-src (Tanaka et al., 1987)
and c-yes (Sukegawa et al., 1987) proteins. Percentage
homologies with amino-acids 1-75 and 76-529 of the predicted c-
fgr protein are shown. Amino-acids 175-529 of the c-fgr protein
are taken from Nishizawa et al. (1986) and Parker et al. (1985).
Chicken c-src sequences are taken from Tanaka & Hanafusa
(1983). Only residues which are not identical to those in the
predicted c-fgr protein are shown. Gaps (-) have been
introduced in order to optimise alignments.
acid 76 in the predicted c-fgr protein to the carboxyl
terminus.
Differential polyadenylation of c-fgr mRNA
As shown in Figure 5, the cDNA clone pFcl 1 is 271 bp
shorter than pFal at the 3' end, and contains there a stretch
of 60 adenosine residues. Polyadenylation at this site could
be directed by the sequence UAUAAA encoded by
nucleotides 2054-2059. Polyadenylation could also be
directed downstream by the sequence AGUAAA encoded at
nucleotides 2335-2340 in pFal. It is possible that the use of
alternative polyadenylation sites accounts for the difference
in size between the 2.9kb and the 3.5kb c-fgr transcripts. In
order to determine whether this is so, radiolabelled antisense
RNA synthesised using the plasmid pF3.4 as a template was
used to probe a Northern blot of polyadenylated RNA from
Raji and BL2-B95/1 cells. The filter was washed at 80°C in
0.1 x SSC/l% SDS. Hybrids between the 9bp sequence
shared by the probe and the RNA species corresponding to
pFcl 1 would not be stable under these conditions. As shown
in Figure 6, the probe hybridised to the 2.9kb transcript
of Raji cells (lane a) and to both the 2.9kb and 3.5kb
transcripts of BL2-B95/1 cells (lane b). Thus, the down-
stream polyadenylation site is used in transcripts of both
sizes, and use of the upstream site presumably contributes to
the apparent heterogeneity of the 2.9kb RNA (Figure 1,
lanes d, h and k).
Discussion
We have shown here that in vitro conversion of three
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1730 1780
pFal ACCAGCCCGGGGATCAGACATAGCCTGTCCGGGCATCAACCCTCTCTGGCGGTGGCCACC
Q P G D Q T *.
p Fc 11 ACCAGCCCGGGGATCAGACATAGCCTGTCCGGGCATCAACCCTCTCTGGCGGTGGCCACC
1790 1840
AGTCCTTGCCAATCCCCAGAGCTGTTCTTCCAAAGCCCCCAGGCTGGCTTAGAACCCCAT
AGTCCTTGCCAATCCCCAGAGCTGTTCTTCCAAAGCCGCCCAGGCTGGCTTAGAACCCCAT
1850 1900
AGAGTCCTAGCATCACCGAGGACGTGGCTGCTCTGACACCACCTAGGGCAACCTACTTGT
AGAGTCCTAGCATCACCGAGGACGTGGCTGCTCTGACACCACCTAGGGCAACCTACTTGT
1910 1960
TTTACAGATGGGGCAAAAGGAGGCCCAGAGCTGATCTCTCATCCGCTCTGGCCCCAAGCA
TTTACAGATGGGGCAAAAGGAGGCCCAGAGCTGATCTCTCATCCGCTCTGGCCCCAAGCA
1970 2020
CTATTTCTTCCTTTTCCACTTAGGCCCCTACATGCCTGTAGCCCTTTCTCACTCCATCCC
CTATTTCTTCCTTTTCCACTTAGGCCCCTACATGCCTGTAGCCCTTTCTCACTCCATCCC
2030 2080
CACCCAAAAGTGCTCAGACCTTGTCTAGTTATTTATAAACTGTATGTACCTCCCTCACTT
CACCCAAAAGTGCTCAGACCTTGTCTAGTTATTTATAAACTGTATGTACCTCCCTC (A) 60
2090 2140
CTCTCCTATCACTGCTTTCCTACTCTCCTTTTATCTCACTCTAGTCCAGGTGCCAAGAAT
2150 2200
TTCCCTTCTACCCTCTATTCTCTTGTGTCTGTAAGTTACAAAGTCAGGAAAAGTCTTGGC
2210 2260
TGGACCCCTTTCCTGCTGGGTGGATGCAGTGGTCCAGGACTGGGGTCTGGGCCCAGGTTT
2270 2320
GAGGGAGAAGGTTGCAGAGCACTTCCCACCTCTCTGAATAGTGTGTATGTGTTGGTTTAT
2330
TGATTCTGTAAATAAGTAAAATGACAA
Figure 5 Nucleotide sequence' of the 3' end of the c-fgr cDNA
clone pFal, with predicted amino-acid sequence. The nucleotide
sequence of the 3' end of the c-fgr cDNA clone pFcl is also
shown. Putative polyadenylation signals are underlined.
a b
3.5.-
2.9
Figure 6 Northern blot of polyadenylated RNA isolated from
Raji (lane a) and BL2-B95/1 (lane b) cells, hybridised with 32P_
labelled antisense RNA synthesised from Bam HI-linearised
pF3.4 DNA. Sizes of transcripts are indicated in kilobases.
recently-established EBV-negative BL cell lines with the
B95.8 strain of EBV results in a dramatic elevation of levels
of two c-fgr transcripts, of 2.9kb and 3.5 kb. A similar
pattern of transcripts has been described in the human B-
lymphocyte cell line IM-9, derived by in vitro infection of
normal peripheral blood B-lymphocytes with EBV (Inoue et
al., 1987). Cheah et al. (1986) were unable to find c-fgr
transcripts in the EBV-negative BL cell lines which they
studied, but we find that low levels are detectable in the
EBV-negative parent cell lines BL2, BL31 and BL41. Many
of the changes in cellular phenotype which accompany EBV-
conversion resemble changes seen during normal B-
lymphocyte activation, most strikingly the acquisition of cell
surface markers such as CD23 and Blast-I (Swendeman &
Thorley-Lawson, 1987). These results raise the possibility,
therefore, that the c-fgr protein is involved in the pathway of
normal B-lymphocyte activation, perhaps as part of a
protein phosphorylation cascade which transduces signals
leading to B-lymphocyte differentiation and proliferation.
Transcripts of the c-fgr gene are not limited to B-
lymphocytes, though, having also been detected in well-
differentiated monocytic cells (Willman et al., 1987) in lung
(Tronick et al., 1985) and in placenta (Nishizawa et al.,
1986). It is not known which cell type(s) express c-fgr in the
latter two tissues, but expression may be a reflection of their
haematopoietic component.
The c-fgr gene is a member of a family which also includes
c-src (Tanaka et al., 1987), fyn (Semba et al., 1987), hck
(Quintrell et al., 1987), Ick (Voronova & Sefton, 1986), tyn
(Yamanashi et al., 1987), c-tkl (Strebhardt et al., 1987) and
c-yes (Sukegawa et al., 1987). Unlike other tyrosine kinases
such as c-erb-B and c-fms these proteins do not appear to be
cell surface receptors, since they are thought to be located at
the cytoplasmic surface of the plasma membrane (Pellman
et al., 1985). The c-fgr gene resembles fyn, hck, tck, tyn and
c-tkl in having a restricted expression pattern, in contrast to
c-src and c-yes whose expression is more widespread.
The proteins encoded by this gene family all have a highly
conserved carboxyl-terminal domain which encodes tyrosine
kinase activity by analogy with pp6Oc-src. The amino-terminal
domains are quite diverged, however, and nucleotide
sequence data presented here shows that the amino-terminal
domain of the c-fgr protein is also quite different from those
of the other members of the family. This sequence divergence
may indicate that the various family members, expressed in
different cell types, have different substrate specificities. It is
unlikely that it engenders differences in intracellular location
since all members of the family, including the predicted c-fgr
protein, as shown here, retain a glycine residue at position
two. In pp6Oc-src this residue is the target for post-
translational myristylation, which is necessary for the
localisation of the protein to the inner surface of cytoplasmic
membranes (Pellman et al., 1985). It is likely, then, that the
c-fgr protein shares the same intracellular location as
pp6Ocsrc. It is also noteworthy that against the general back-
ground of diversity in amino-terminal sequences, the pre-
dicted tyn, hck, and fyn proteins (but not c-src or c-yes)
contain peptides with homology to the sequence Tyr-Gly-
Pro-Asp-Pro-Thr-Lys found at positions 34-40 in the
predicted c-fgr protein (Figure 4). In addition, the fyn
protein has homology to the sequfence Ile-Pro-Asn-Tyr-Ser-
Asn-Phe found at positions 50-57 in the c-fgr protein. The
functional significance of these peptides, if any, is unclear.
Inoue et al. (1987) and Katamine et al. (1988) have
recently reported nucleotide sequence derived from c-fgr
cDNA clones. The nucleotide sequence of the 5' end of the
c-fgr cDNA clone pFd97 (Figures 2 and 3), is identical to
that reported by Inoue et al. (1987), starting 3 bp down-
stream of their sequence. However, both our sequence and
that of Inoue et al. (1987) differ in the 5' untranslated region
from that reported by Katamine et al. (1988). This latter
sequence was derived from a cDNA clone representing an
incompletely processed c-fgr transcript containing intron 2.
It is therefore likely that the sequence of the 5' untranslated
region reported by Katamine et al. (1988) is in fact derived
from intron 1, and that the sequence shown in Figure 3 is
that of the 5' untranslated region of the mature mRNA.708 P.M. BRICKELL & M. PATEL
The 5' untranslated regions of the mRNAs encoding
different members of the tyrosine kinase family may have a
role in regulating their differential expression. Marth et al.
(1988) have recently shown that the 5' untranslated region of
lck mRNA contains AUG codons which reduce the
efficiency of translation from the authentic initiation codon.
As shown here, the 5' untranslated region of the c-fgr
mRNA contains two AUG codons, both of which are out-
of-frame with respect to the initiating AUG. One of these, at
nucleotides 101-103, obeys the rules of Kozak (1987) and so
could be recognised by the 40S mammalian ribosomal
subunit and be used to initiate translation, masking the
authentic AUG. Kozak (1987) has noted that 65% of
sequenced proto-oncogene mRNAs have AUGs in their 5'
untranslated regions, in contrast to fewer than 10% of 700
other mammalian genes surveyed, suggesting that cells might
regulate the use of translational start sites in these mRNAs.
We have also demonstrated, by the nucleotide sequencing
of c-fgr cDNA clones, that the mature c-fgr mRNA can be
polyadenylated at either of two sites. The upstream poly-
adenylation signal, at nucleotides 2054-2059 does not encode
the usual AAUAAA consensus sequence (Proudfoot &
Brownlee, 1976), but UAUAAA, a sequence which has also
been found to be used as a polyadenylation signal in the
gene encoding hepatitis B virus surface antigen (McLauchlan
et al., 1985). The c-fgr cDNA clones of Inoue et al. (1987)
and Katamine et al. (1988) have the extended 3' end of
pFal, and the data of Katamine et al. (1988) show that the
RNA species from which their cDNA clones derive are
polyadenylated 13bp downstream of the 3' end of pFal,
presumably using the non-consensus polyadenylation signal
AGUAAA encoded at nucleotides 2335-2340. This sequence
is also used as a polyadenylation signal in the genomes of
baboon erythroblastosis virus and mouse mammary tumour
virus (McLauchlan et al., 1985). The sequence AAUAAG
encoded at nucleotides 2331-2336 is probably non-
functional, since it has been shown not to direct poly-
adenylation of transcripts of a mutant a2-globin gene in a
case of ax-thalassaemia (Higgs et al., 1983). On the basis of
the numbers of cDNA clones of each type isolated, the
downstream polyadenylation site appears to be used most
frequently, Alternative polyadenylation does not account for
the size difference between the 2.9kb and 3.5kb c-fgr
transcripts but probably contributes to heterogeneity in the
lower molecular weight band on Northern blots. This result
agrees with recent data from Katamine et al. (1988), which
suggests that the 3.5 kb transcript is an incompletely
processed precursor, containing intron 2 of the c-fgr gene.
Several genes have been characterised which contain
alternative polyadenylation sites. In some cases, such as the
bovine and human kininogen genes (Kitamura et al., 1985)
and the immunoglobulin iu heavy chain gene (Rogers et al.,
1980), the use of alternative polyadenylation sites generates
proteins with different carboxyl-termini. In the case of the
immunoglobulin ,u heavy chain gene, polyadenylation site
selection is developmentally regulated. The c-fgr gene
resembles the rat disulphide isomerase gene (Edman et al.,
1985) and the hamster HMG CoA reductase gene (Reynolds
et al., 1984), however, in which the choice of poly-
adenylation site does not affect the protein product. It is not
clear whether the choice of polyadenylation sites in the case
of c-fgr is regulated. If it were, it could influence the stability
of c-fgr mRNA in different cell types and thus be a
mechanism for regulation of c-fgr gene expression.
Finally, the availability to us of cDNA clones representing
5' sequences of the c-fgr mRNA now allows us to map the
limits of the c-fgr transcription unit in cosmid genomic
clones (our unpublished data), in order to study the basis of
the regulation of c-fgr gene expression during EBV-
conversion, and B-lymphocyte activation. In addition, the
predicted amino-acid sequence of divergent portions of the c-
fgr protein allows the synthesis of peptides for production of
specific antisera with which to study the expression and
function of this protein during the activation of
B-lymphocytes.
This work was funded by the Cancer Research Campaign. We thank
Professor R.K. Craig for helpful discussions and critical reading of
this manuscript.
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